Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

600196

Clasificación en acciones #2196
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical... Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical business in Mainland China and internationally. It operates through five segments: Pharmaceuticals, Medical Devices and Medical Diagnosis, Medical Services, Medical Distribution and Retail, and Others. The company is involved in the pharmaceutical manufacturing in the therapeutic areas of solid oncology, including tumors and hematologic malignancies, as well as immune-inflammatory disorders, metabolism and digestive systems, anti-infection, central nervous system, cardiovascular system, and APIs and intermediates. It also offers mRNA vaccines; medical aesthetic devices, such as medical aesthetic capital equipment, aesthetic dentistry, injectables, and personal care business units; mechanical ventilation devices under the Breas brand; and mobile pre-hospital care; professional in-hospital surgery and covers medical devices; and high-end surgical robots and medical consumables. In addition, the company provides diagnostics solutions comprising biochemical diagnostics, immune diagnostics, molecular diagnostics, microbiological diagnostics, pathological diagnostics, and chronic care management; and healthcare services, specialized medical treatment, online and offline medical services, and insurance services. Further, it engages in the operation of hospitals; and distribution and retail of healthcare products. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.
Precio por acción
$3.40
Capitalización bursátil
$9.07B
Cambio (1 día)
-1.61%
Cambio (1 año)
-16.08%
País
CN
Comercio Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196)

Categoría

Healthcare
Historial de desdoblamientos de acciones de Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196)
La acción Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (símbolo: 600196) tuvo un total de 6 desdoblamientos.
El desdoblamiento más reciente ocurrió el Jul 26, 2010.
Una acción 600196 comprada antes de Feb 02, 1999 equivaldría hoy a 9.126 acciones 600196.
Lista de desdoblamientos de acciones
Año Desdoblamiento Multiplicador Multiplicador acumulado
2010-07-26 3:2 x1.5 x9.126
2007-06-08 13:10 x1.3 x6.084
2004-06-24 2:1 x2 x4.68
2002-06-18 13:10 x1.3 x2.34
2000-03-31 6:5 x1.2 x1.8
1999-02-02 3:2 x1.5 x1.5
Desdoblamientos de acciones de empresas similares o competidoras
Empresa Número de desdoblamientos de acciones Multiplicador acumulado País
0 -
DE
0 -
DE
0 -
JP
0 -
CH
5 x119
IN